Supplementary Figure 1. Ex-vivo efferocytosis
Alveolar macrophages obtained from subjects one month into their recovery from CAP are co-cultured for 90 minutes with autologous apoptotic neutrophils. For this image the ex-vivo assay was conducted in a dedicated cell culture chamber at 37°C, 5% CO2 mounted on a confocal microscope and the image is a composite of simultaneously acquired bright-field and blue laser images. The neutrophils have been stained and fluoresce bright green.
Macrophages can be seen extending their podocytes towards neutrophils prior to efferocytosis.
Supplementary Figure 2. Ex-vivo efferocytosis flow-cytometry gating strategy
From left to right, the first 3 pairs of plots are controls run at the time of each patient's efferocytosis experiment.
Cells selected by light scatter in gate [F] are quenched, green stained neutrophils and their FITC fluorescence is seen in the histogram beneath.
Gate [D] excludes all but 0.11% of neutrophils but includes alveolar macrophages.
Gate [E] excludes all but 0.1% of macrophages which have been co-cultured with unstained apoptotic neutrophils as a control experiment.
In the pair of plots on the far right the macrophages are selected by light scatter in gate [D] and those macrophages that fall within gate [E] have a higher FITC signal than is seen in the control experiment. We infer that these FITC high macrophages have ingested green apoptotic neutrophils. prior to admission and represented how they felt before the pneumonia began. CAP-sym was repeated at the one month follow-up visit just prior to bronchoscopy.
Recovery was calculated as the percentage improvement in CAP-sym score at one month compared to the CAP-sym score at presentation. This recovery measure is then plotted against the efferocytosis result for 22 subjects. Linear modelling revealed a non-statistically significant trend towards increasing recovery with increasing efferocytosis as displayed by the blue line (shaded area = 95% CI around the position of the line).
